Work Packages

Dialogue & Participation

WP1 is about building a common approach concerning the societal challenges among the different project
partners and ensuring the overall scientific coordination of the MMLAP.

WP1 main objectives are:

Study & Analysis

WP2 is about the state of the art research and existing studies on pandemics, and their wider societal implications, research and innovation in this area, and the operational and regulatory environment. Its main objectives are to establish a baseline knowledge about:

Action Plan Definition

WP3 aims to design the Action Plan and its main components. WP3 objectives are:

  1. the definition of the overall architecture of the Action Plan;
  2. a roadmap towards the incorporation of user-driven open innovation in the area of pandemic preparedness and response;
  3. an handbook of the action including also detailed timetable;
  4. a collection of tools – tool box – including checklists, guidelines, and downloadable templates.

Citizen Consultation

WP4 will carry out a public consultation. Its main objectives are:

Mobilization and Mutual Learning

WP5 aims to carry out MML actions at European, national, and local level. Notably it will:

  1. promote social media mobilization;
  2. establish a Best Practice Platform and Stakeholder Portal that may support mutual learning activities;
  3. create a web of local initiatives to promote mobilization and mutual learning at local level and to enhance the transferability of the most effective policies and practice.

Policy Watch

WP6 will ensure a reflection on EU strategic priorities about pandemics and a regular monitoring other EU related initiatives and policy developments at local, national and European levels, in order to better connect with policy cycles. WP6 will also aim to liaise with Research or Policy EC services involved in Challenges 1 (Health, demographic change and wellbeing).

Communication

WP7 aims to:

Evaluation

WP8 aims to carry out an in-depth independent evaluation of the methodology and implementation progress of ASSET and of its potential impacts on citizens and civil society, throughout the duration of the project, in relation to its objectives and expected impacts. WP8 objectives are to provide:

  1. the continuous project monitoring and ongoing evaluation;
  2. ex-post evaluation of project WPs and critical activities.

Legacy

WP9 will set up a strategy for ensuring post-action sustainability and to give future participants, wishing to pursue ASSET, the means to efficiently implement ASSET recommendations. WP9 objectives are:

Management

The Project Management Office aims at properly initiating the management tools, running the appropriate monitoring and control procedures, and assisting all the beneficiaries for optimal performance and reporting up to the end of the project. This includes, but is not limited to:

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence